College of Medicine receives eight-year accreditation
The Liaison Committee on Medical Education (LCME) has granted the College of Medicine’s educational program leading to the MD degree an eight-year term of accreditation.
In a message today to faculty staff and students, Andrew Filak Jr., MD, senior vice president for health affairs and Christian R. Holmes Professor and dean, congratulated everyone for their efforts that went into the preparation for the October 2019 LCME survey visit. “This full, eight-year accreditation is due to your enduring commitment to our missions of education, research and patient care that is the foundation of our medical degree program. I especially want to thank Pamela Baker, PhD, associate dean for medical education and lead of the LCME self-study, the LCME Task Force Steering committee and everyone who served on our six subcommittees,” he said.
The LCME determined that the college was in compliance with all 12 standards, the highest possible mark. The college was directed to monitor five issues where more data are required to confirm that an implemented change is addressing the issue identified as part of the self-study process.
“This was a truly successful visit particularly in a climate where accreditation standards are increasingly more stringent,” Filak said.
The medical education program’s next full survey will take place during the 2027-2028 academic year.
Related Stories
Is a colonoscopy painful?
May 13, 2026
The University of Cincinnati's Susan Kais, MD, assistant professor of clinical medicine in the Division of Gastroenterology and Hepatology in the College of Medicine and UC Health gastroenterologist, recently appeared on the ARC Cincinnati morning program on Local 12/WKRC-TV to answer common questions from viewers about colonoscopies and to dispel myths.
University of Cincinnati graduate programs rise in national rankings across high-demand fields
May 13, 2026
University of Cincinnati graduate programs climbed in the latest U.S. News & World Report rankings, led by strong gains in workforce-focused fields including public health, clinical psychology and business.
UC achieves first-in-world remission of aggressive pituitary tumor with novel immunotherapy
May 13, 2026
Researchers at the University of Cincinnati Gardner Neuroscience Institute’s Brain Tumor Center have been confirmed as the first in the world to achieve complete remission of a rare pituitary cancer using a novel immunotherapy treatment. The findings were published in Surgical Neurology International and recently featured in The Cancer Letter.